LitAlert ~~ GeneLit.com

    • PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival.
    • Shao F, Duan Y, Zhao Y, Li Y, Liu J, Zhang C, He S.
    • Aging (Albany NY). 2021 Mar 11;13. doi: 10.18632/aging.202724. Epub ahead of print.
    • Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer.
    • Bernard PS, Wooderchak-Donahue W, Wei M, Bray SM, Wood KC, Baiju Parikh B, McMillin GA.
    • Cancers (Basel). 2021 Mar 11;13(6):E1219. doi: 10.3390/cancers13061219.